TechnologiesTechnologiesTechnologiesTechnologies
  • Home
  • Company
    • Our Vision
    • History
    • Current State
    • Contact
  • R&D Projects
    • Anti aging research
    • Mitochondrial transfer technology
    • Anticancer vaccine research
  • Technologies
    • Cancer Immunotherapy
    • Autoimmune and Allergic Disorders Immunotherapy
    • Chronic Inflammatory Diseases Immunotherapy
    • OPI Therapy for Motor and Skin Diseases
    • Storage of Immune Cells
  • R&D Products
    • Cord blood plasma
    • Mesenchymal Stem Cells
    • Exosomes
    • Polyantigenic anticancer vaccine
    • Cell lines
    • Cell-based Products
  • Clinic
  • EU projects
  • News
✕

Technologies

  • Home
  • Technologies

Innovita Research has developed some experimental technologies that can be provided for scientific and other customers. In many cases we can help with the preparation and application of these technologies under customer local governmental rules/requirements.

  • Cancer immunotherapy
  • T-cell immunotherapy (T-cell vaccination) for autoimmune and allergic disorders
  • Adoptive cell-based immunotherapy for chronic inflammatory diseases
  • OPI therapy for motor and skin diseases
  • Storage of immune cells

Related science news

  • Research explores how Alzheimer’s alters the brain’s electrical activity
    March 12, 2026
  • ‘Personal lives’ of lung cancer cells help predict response to treatment
    March 11, 2026
  • Human liver tissue cell architecture reconstructed in 3D
    March 5, 2026
  • Using Machine Learning to Develop Personalized Vaccines for Cancer
    March 4, 2026
  • Cracking a ‘holy grail’ challenge in cancer cell therapy
    March 3, 2026
More news.
© 2017 - 2026 Innovita Research | Privacy policy